Try our beta test site
2 studies found for:    BNC105P
Show Display Options
Rank Status Study
1 Active, not recruiting BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Everolimus;   Drug: BNC105P
2 Withdrawn BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Gemcitabine;   Drug: BNC105P

Study has passed its completion date and status has not been verified in more than two years.